Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 2 |
2018 | 1 |
2019 | 3 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
Int J Cancer. 2020 Jul 15;147(2):413-422. doi: 10.1002/ijc.32783. Epub 2019 Dec 13.
Int J Cancer. 2020.
PMID: 31714586
Free PMC article.
Clinical Trial.
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study.
Westin SN, Sill MW, Coleman RL, Waggoner S, Moore KN, Mathews CA, Martin LP, Modesitt SC, Lee S, Ju Z, Mills GB, Schilder RJ, Fracasso PM, Birrer MJ, Aghajanian C.
Westin SN, et al.
Gynecol Oncol. 2019 Dec;155(3):420-428. doi: 10.1016/j.ygyno.2019.09.024. Epub 2019 Oct 15.
Gynecol Oncol. 2019.
PMID: 31623857
Free PMC article.
Clinical Trial.
Item in Clipboard
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
Konstantinopoulos PA, Barry WT, Birrer M, Westin SN, Cadoo KA, Shapiro GI, Mayer EL, O'Cearbhaill RE, Coleman RL, Kochupurakkal B, Whalen C, Curtis J, Farooq S, Luo W, Eismann J, Buss MK, Aghajanian C, Mills GB, Palakurthi S, Kirschmeier P, Liu J, Cantley LC, Kaufmann SH, Swisher EM, D'Andrea AD, Winer E, Wulf GM, Matulonis UA.
Konstantinopoulos PA, et al.
Lancet Oncol. 2019 Apr;20(4):570-580. doi: 10.1016/S1470-2045(18)30905-7. Epub 2019 Mar 14.
Lancet Oncol. 2019.
PMID: 30880072
Free PMC article.
Clinical Trial.
Item in Clipboard
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN.
Pal N, et al.
Obstet Gynecol. 2018 Jan;131(1):109-116. doi: 10.1097/AOG.0000000000002390.
Obstet Gynecol. 2018.
PMID: 29215513
Free PMC article.
Item in Clipboard
Factors prognostic of survival in advanced-stage uterine serous carcinoma.
Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN.
Holman LL, et al.
Gynecol Oncol. 2017 Jul;146(1):27-33. doi: 10.1016/j.ygyno.2017.04.018. Epub 2017 Apr 30.
Gynecol Oncol. 2017.
PMID: 28465008
Free PMC article.
Item in Clipboard
Individualized Medicine in Ovarian Cancer: Are We There Yet?
Westin SN, Coleman RL.
Westin SN, et al.
Gynecol Oncol. 2017 Feb;144(2):229-231. doi: 10.1016/j.ygyno.2017.01.006.
Gynecol Oncol. 2017.
PMID: 28089051
Free PMC article.
No abstract available.
Item in Clipboard
Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.
Liu J, Westin SN.
Liu J, et al.
Gynecol Oncol. 2016 Apr;141(1):65-71. doi: 10.1016/j.ygyno.2016.01.003.
Gynecol Oncol. 2016.
PMID: 27016231
Free PMC article.
Review.
Item in Clipboard
Cite
Cite